We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBNY
651
DELISTED
Signature Bank
SBNY
| $3.74M | 0.01% |
+35,000
| New | +$3.45M |
|
|
AAWW
652
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $3.63M | 0.01% |
84,247
-57,584
| -41% | -$2.02M |
|
|
VRT.WS
653
DELISTED
Vertiv Holdings Co Warrants, each whole warrant exercisable for one share of Class A Common Stock at
VRT.WS
| $3.59M | 0.01% |
900,000
| – | – |
|
654
Franklin Resources
BEN
$18.3B
| $3.54M | 0.01% |
169,000
+44,800
| +36% | +$845K |
|
|
ARYBU
655
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
| $3.48M | 0.01% |
+300,000
| New | +$3.3M |
|
656
Compass Minerals
CMP
$1.26B
| $3.44M | 0.01% |
+70,491
| New | +$3.27M |
|
|
IPHA
657
Innate Pharma
IPHA
$168M
| $3.42M | 0.01% |
500,000
| – | – |
|
|
NINE
658
DELISTED
Nine Energy Service
NINE
| $3.39M | 0.01% |
1,736,470
-298,773
| -15% | -$502K |
|
|
ARYAW
659
DELISTED
ARYA Sciences Acquisiton Corp. Warrant
ARYAW
| $3.38M | 0.01% |
625,000
| – | – |
|
660
Quanta Services
PWR
$105B
| $3.34M | 0.01% |
85,147
+19,700
| +30% | +$703K |
|
661
Western Union
WU
$2.26B
| $3.31M | 0.01% |
+153,273
| New | +$3.11M |
|
662
IPG Photonics
IPGP
$3.97B
| $3.3M | 0.01% |
20,600
+15,700
| +320% | +$2.24M |
|
663
EverQuote
EVER
$834M
| $3.24M | 0.01% |
55,772
| – | – |
|
664
Principal Financial Group
PFG
$24.9B
| $3.24M | 0.01% |
78,068
+500
| +0.6% | +$18.2K |
|
665
Xerox
XRX
$413M
| $3.19M | 0.01% |
208,300
+4,100
| +2% | +$70.7K |
|
666
COPT Defense Properties
CDP
$4.25B
| $3.17M | 0.01% |
124,920
-360,080
| -74% | -$8.98M |
|
667
H&R Block
HRB
$5.84B
| $2.96M | 0.01% |
207,000
-13,700
| -6% | -$217K |
|
668
Highwoods Properties
HIW
$3.56B
| $2.87M | 0.01% |
+76,841
| New | +$2.86M |
|
669
Conduent
CNDT
$273M
| $2.85M | 0.01% |
1,194,283
+865,134
| +263% | +$2.01M |
|
|
PROS
670
DELISTED
ProSight Global, Inc.
PROS
| $2.67M | 0.01% |
300,000
| – | – |
|
671
Bio-Rad Laboratories Class A
BIO
$9.23B
| $2.62M | 0.01% |
+5,800
| New | +$2.56M |
|
672
Huntington Bancshares
HBAN
$35.7B
| $2.54M | 0.01% |
281,100
+2,500
| +0.9% | +$22.1K |
|
673
Suncor Energy
SU
$76.2B
| $2.53M | 0.01% |
+150,000
| New | +$2.56M |
|
674
StoneCo
STNE
$2.75B
| $2.52M | 0.01% |
65,000
-75,000
| -54% | -$2.19M |
|
675
Kearny Financial
KRNY
$613M
| $2.45M | 0.01% |
300,000
+200,000
| +200% | +$1.67M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.